11,673 Followers on Owler

Takeda

Takeda is a manufacturer, marketer and distributor of pharmaceutical products. Read more

Christophe Weber's photo - President & CEO of Takeda

President & CEO

Christophe Weber

CEO Approval Rating

71/100

Founded:

1781

Status:

PublicIndependent CompanyTokyo Stock Exchange4502

TAKEDA TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Janssen is one of Takeda's top rivals. Janssen is a Private company that was founded in 1953 in Titusville, New Jersey. Like Takeda, Janssen also works within the Pharmaceuticals industry. Compared to Takeda, Janssen has 10,000 fewer employees.

AbbVie is seen as one of Takeda's biggest rivals. AbbVie was founded in 2013 in North Chicago, Illinois. Like Takeda, AbbVie also competes in the Pharmaceuticals sector. AbbVie generates $21.2B more revenue than Takeda.

UCB is one of Takeda's top competitors. UCB was founded in 1928, and its headquarters is in Brussels, Brussels-Capital Region. UCB competes in the Biotechnology industry. UCB has 41,629 fewer employees than Takeda.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is AstraZeneca a competitor of Takeda?

Takeda Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$29B

Takeda's revenue is the ranked 7th among it's top 10 competitors. The top 10 competitors average 20.2B. Over the last four quarters, Takeda's revenue has decreased by 31.5%. Specifically, in Q1 2021's revenue was $5.4B; in Q4 2020, it was $8.1B; in Q3 2020, it was $7.6B; in Q2 2020, Takeda's revenue was $7.9B.

Takeda Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Maverick Therapeutics, Inc.

Mar 2021

Source »
$525M
Maverick is a biopharmaceutical company that develops and commercializes T-cell based immunotherapies for the treatment of cancer.
PvP Biologics, Inc.

Feb 2020

Source »
$330M
PvP Biologics specializes in developing an oral enzyme for the treatment of celiac disease.
Shire Plc

May 2018

Source »
$62.4B
Shire is a biopharmaceutical company that develops therapeutics for rare diseases and also offers patient advocacy services.
TiGenix N.V.

Jan 2018

Source »
$626.4M
TiGenix is a cell therapy company that develops and commercializes novel therapeutics for the treatment of autoimmune and inflammatory diseases.
Ariad Pharmaceuticals Inc

Jan 2017

Source »
$5.2B
ARIAD is engaged in the discovery, development and commercialization of drugs for the patients with lung cancer.

These are all the companies that Takeda has acquired. Takeda has acquired 9 companies and its latest acquisition was Maverick Therapeutics, Inc. in Mar 2021. Maverick is a biopharmaceutical company that develops and commercializes T-cell based immunotherapies for the treatment of cancer.

Takeda Funding History

Since Takeda was founded in 1781, it has participated in 2 rounds of funding. In total Takeda has raised $7.5B. Takeda's last funding round was on Jun 2018 for a total of $7.5B

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
Jun 2018
$7.5B
Grant
May 2016
$38M

Since Takeda was founded in 1781, it has participated in 2 rounds of funding. In total Takeda has raised $7.5B. Takeda's last funding round was on Jun 2018 for a total of $7.5B

Takeda Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Adaptate is an England-based biotechnology company that researches, develops, and commercializes antibody gamma delta T-cell therapeutics for the treatment of cancer diseases.
$18M
Apr 18, 2021
Series A
-
Aspen Health is a healthcare management platform that provides clinical pharmacy and medication therapy management solutions for patients.
$23M
Jan 06, 2021
Series B
-
Bridge Medicines is a biotechnology firm that develops and commercializes therapies for the treatment of cancer and infectious diseases.
$10M
Nov 11, 2020
Equity
-
Enterome develops and commercializes therapies for the treatment of microbiome, cancer and metabolic diseases.
$52.6M
Jun 24, 2020
Series E
-
Amwell is a web-based telehealth platform that connects patients with healthcare providers via video, phone and email.
$194M
May 19, 2020
Series C
Sep 17, 2020

These are all the companies that Takeda has invested in. Takeda has invested 9 companies and its latest investment was Maverick Therapeutics, Inc. in Mar 2021. Maverick is a biopharmaceutical company that develops and commercializes T-cell based immunotherapies for the treatment of cancer.

Takeda News

June 16, 2021FinanzNachrichten

Takeda Pharmaceuticals Marks its 240th Founding Anniversary

DUBAI, UAE, June 16, 2021 /PRNewswire/ -- Takeda Pharmaceuticals Company (TSE: 4502) (NYSE: TAK) ("Ta... See more »
June 16, 2021FiercePharma

Boehringer, Lilly and Takeda join matchmaker PharmStars' digital health accelerator

Boehringer, Lilly and Takeda join matchmaker PharmStars' digital health accelerator bbulik Tue, 06/15... See more »
June 10, 2021BioSpace

Codexis and Takeda Expand Strategic Collaboration and License Agreement to Discover Additional Gene Therapy for a Fourth Rare Genetic Disorder

Codexis, Inc. announced the expansion of its strategic collaboration and license agreement with Taked... See more »
June 9, 2021Markets Insider

Takeda introduces the In Their Shoes experience to the Middle East in support of the IBD patient community

DUBAI, UAE, June 9, 2021 /PRNewswire/ -- Takeda (TSE: 4502) (NYSE: TAK) has introduced the 'In Their ... See more »
June 3, 2021FinSMEs

Transine Therapeutics Raises 9.1 in Funding

Transine Therapeutics, a Cambridge UK-based biotechnology company which specializes in development of... See more »
June 3, 2021FiercePharma

Takeda launches GI education effort aimed doctors in advance of vonoprazan's FDA submissions

Takeda launches GI education effort aimed doctors in advance of vonoprazan's FDA submissions sharon.c... See more »
May 28, 2021Manufacturing Chemist

Takeda to evaluate Aptamer Group reagents for drug development

Based on oligonucleotide molecules, Optimers (which the company describes as optimised aptamer reagen... See more »

Takeda Press Releases

May 14, 2021Business Wire

Takeda oferece resultados resilientes para o ano fiscal de 2020 com margens fortes e fluxo de caixa robusto; espera-se que o crescimento da receita subjacente acelere no AF2021

OSAKA, Japão--(BUSINESS WIRE)--A Takeda Pharmaceutical Company Limited (TOKYO: 4502) (NYSE: TAK) ("Ta... See more »
April 1, 2021Business Wire

Takeda Organiza Chamada de Oportunidades de Mercado da Linha de Produtos Wave 1

CAMBRIDGE, Massachusetts e OSAKA, Japão--(BUSINESS WIRE)--A Takeda Pharmaceutical Company Limited (TS... See more »
March 17, 2021Cision Canada

Health Canada approves new indication for lung cancer treatment option ALUNBRIG

/CNW/ - Takeda Canada Inc. is pleased to announce that Health Canada has issued ALUNBRIG® (brigatinib... See more »
March 10, 2021Business Wire

Maverick TherapeuticsT

日本大阪和加州布里斯班--(BUSINESS WIRE)--(美國商業資訊)--武田藥品工業株式會社(Takeda Pharmaceutical Company Limited, TSE:4502/NY... See more »
March 1, 2021Business Wire

Takeda Earns the Best Place To Work Certification in Bulgaria

SOFIA, Bulgaria--(BUSINESS WIRE)-- #Bulgaria--Takeda been officially recognized as one of the best pl... See more »
February 24, 2021Cision Canada

Takeda Canada Celebrates Resilient Rare Stars on Rare Disease Day

/CNW/ - Takeda Canada Inc. proudly recognizes Durhane Wong-Rieger as one of five global rare disease ... See more »
February 24, 2021Business Wire

Xilio Therapeutics Raises $95 Million in Series C Financing to Advance Potent Tumor-Selective Immuno-Oncology Pipeline

WALTHAM, Mass.--(BUSINESS WIRE)--Xilio Therapeutics, a biotechnology company developing potent, tumor... See more »

Social Media

Takeda Headquarters

1-1, Nihonbashi-Honcho 2-chome Chuo-ku

Tokyo, Tōkyō Prefecture103-8668

81-3-3278-2111

Driving Directions »

Trending Companies

Takeda Summary

ABOUT

Overview

Takeda is a manufacturer, marketer and distributor of pharmaceutical products. Takeda was founded in 1781. Takeda's headquarters is located in Tokyo, Tōkyō Prefecture, JP 103-8668. It has raised 7.5B in 2 rounds. The latest round was in Jun 2018. Some...

CEO

Takeda's President & CEO, Christophe Weber, currently has an approval rating of 71%. Takeda's primary competitors are Janssen, AbbVie & UCB.

Website

takeda.com

Frequently Asked Questions about Takeda

  1. When was Takeda founded?

    Takeda was founded in 1781
  2. Who is Takeda's CEO?

    Takeda's CEO is Christophe Weber
  3. How much revenue does Takeda generate?

    Takeda generates $29B in revenue
  4. How much funding does Takeda have?

    Takeda has historically raised $7.5B in funding
  5. Where is Takeda's headquarters?

    Takeda's headquarters is in Tokyo Tōkyō Prefecture, JP
  1. How many employees does Takeda have?

    Takeda has 50,000 employees
  2. What sector does Takeda operate in?

    Takeda is in Pharmaceuticals
  3. Who are Takeda's competitors?

    Takeda's top competitors are Janssen, AbbVie, UCB
  4. Who has Takeda invested in?

    Takeda's has invested in companies such as Adaptate, Aspen RxHealth, Bridge Medicines